[go: up one dir, main page]

NO933000D0 - Anvendelse av c1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer - Google Patents

Anvendelse av c1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer

Info

Publication number
NO933000D0
NO933000D0 NO933000A NO933000A NO933000D0 NO 933000 D0 NO933000 D0 NO 933000D0 NO 933000 A NO933000 A NO 933000A NO 933000 A NO933000 A NO 933000A NO 933000 D0 NO933000 D0 NO 933000D0
Authority
NO
Norway
Prior art keywords
prophylaxy
inactivator
medicine
preparation
treatment
Prior art date
Application number
NO933000A
Other languages
English (en)
Other versions
NO933000L (no
Inventor
Bernd Eisele
Ulrich Delvos
Andreas Jessel
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of NO933000D0 publication Critical patent/NO933000D0/no
Publication of NO933000L publication Critical patent/NO933000L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO933000A 1992-08-24 1993-08-23 Anvendelse av C1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer NO933000L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4227762A DE4227762A1 (de) 1992-08-24 1992-08-24 Verwendung eines Kallikrein-Inhibitors zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie bestimmter Krankheiten

Publications (2)

Publication Number Publication Date
NO933000D0 true NO933000D0 (no) 1993-08-23
NO933000L NO933000L (no) 1994-02-25

Family

ID=6466096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933000A NO933000L (no) 1992-08-24 1993-08-23 Anvendelse av C1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer

Country Status (9)

Country Link
US (1) US5939389A (no)
EP (1) EP0586909A3 (no)
JP (1) JPH06157343A (no)
KR (1) KR100290753B1 (no)
AU (1) AU671287B2 (no)
CA (1) CA2104636C (no)
DE (2) DE4227762A1 (no)
IL (1) IL106776A0 (no)
NO (1) NO933000L (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227762A1 (de) * 1992-08-24 1994-03-03 Behringwerke Ag Verwendung eines Kallikrein-Inhibitors zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie bestimmter Krankheiten
JP2000507204A (ja) * 1995-12-18 2000-06-13 ステイヒテイング・サンキン・ブロードボールジーニング Ｃ１―インヒビターの補体及び血液凝固阻害特性の強化
US20040152635A1 (en) * 1998-06-22 2004-08-05 Albrecht Groner Modified C1 esterase inhibitor for blocking the infectiousness of HIV
DE19827750C1 (de) 1998-06-22 1999-07-29 Centeon Pharma Gmbh Verfahren zum Abtrennen von HIV aus einer Flüssigkeit
US7067713B2 (en) 2000-01-31 2006-06-27 Pharming Intellectual Property B.V. C1 Inhibitor produced in the milk of transgenic non-human mammals
AU2006203549B2 (en) * 2000-01-31 2008-10-09 Pharming Intellectual Property B.V. C1 inhibitor produced in the milk of transgenic mammals
ES2299473T3 (es) * 2000-01-31 2008-06-01 Pharming Intellectual Property B.V. Inhibidor de c1 humano producido en la leche de mamiferos transgenicos.
WO2004100982A1 (en) 2003-05-16 2004-11-25 Pharming Intellectual Property B.V. C1 inhibitor with short half-life for transient treatment
SI3028716T1 (sl) 2006-10-10 2021-01-29 Regenesance B.V. Komplementarna inhibicija za izboljšano regeneracijo živcev
WO2013041677A1 (en) 2011-09-24 2013-03-28 Csl Behring Gmbh Combination therapy using immunoglobulin and c1-inhibitor
DK2793935T3 (en) 2011-12-22 2016-09-05 Csl Behring Gmbh Use of C1 inhibitor in the treatment of secondary edema in the central nervous system.
EP2961422B1 (en) 2013-02-28 2016-09-28 CSL Behring GmbH Therapeutic agent for amniotic fluid embolism
WO2014135694A1 (en) 2013-03-08 2014-09-12 Csl Behring Ag Treatment and prevention of remote ischemia-reperfusion injury
KR20160026905A (ko) 2013-06-28 2016-03-09 체에스엘 베링 게엠베하 인자 ｘｉｉ 억제제 및 ｃ1-억제제를 이용한 병용 치료요법
WO2016196070A1 (en) 2015-06-03 2016-12-08 Children's Hospital Medical Center Compositions and methods for treating neonatal biliary atresia
EP3493832A1 (en) 2016-08-05 2019-06-12 CSL Behring GmbH Pharmaceutical formulations of c1 esterase inhibitor
EP3504648A1 (en) 2016-08-23 2019-07-03 CSL Behring GmbH Method of preventing acute attacks of hereditary angioedema associated with c1 esterase inhibitor deficiency
JP7410019B2 (ja) 2017-09-15 2024-01-09 シーダーズ－サイナイ メディカル センター 臓器移植患者における臓器機能を改善するための方法
KR20230110563A (ko) 2020-11-20 2023-07-24 체에스엘 베링 게엠베하 항체 매개 거부 반응의 치료 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228502A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung des c1-inaktivators und seine verwendung
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6
US5030578A (en) * 1989-07-10 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Process for the purification of C1-inhibitor
EP0512090B2 (en) * 1990-10-16 2006-11-22 Sonoran Desert Chemicals LLC Treatment of inflammation
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
DE4227735C2 (de) * 1992-08-21 1995-10-12 Leybold Ag Anordnung zum berührungslosen Messen der Dicke von Schichten
DE4227762A1 (de) * 1992-08-24 1994-03-03 Behringwerke Ag Verwendung eines Kallikrein-Inhibitors zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie bestimmter Krankheiten

Also Published As

Publication number Publication date
AU671287B2 (en) 1996-08-22
CA2104636C (en) 2003-11-11
EP0586909A3 (de) 1995-04-05
IL106776A0 (en) 1993-12-08
JPH06157343A (ja) 1994-06-03
US5939389A (en) 1999-08-17
KR940003564A (ko) 1994-03-12
DE4244735A1 (de) 1994-03-31
EP0586909A2 (de) 1994-03-16
DE4227762A1 (de) 1994-03-03
NO933000L (no) 1994-02-25
CA2104636A1 (en) 1994-02-25
AU4477893A (en) 1994-03-03
KR100290753B1 (ko) 2001-09-17

Similar Documents

Publication Publication Date Title
NO933000D0 (no) Anvendelse av c1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
FI941979L (fi) Farmaseuttiset tuotteet kasvainsairausten hoitamiseksi ja menetelmä niiden valmistamiseksi
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
SG49658A1 (en) Treatment of condition and disease
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
DK0630181T3 (da) Ernæringsprodukt til kvæstede og kirurgiske patienter
EP0402467A4 (en) Catheter tube and endoscope
GB2277826B (en) Surgical and/or clinical apparatus
EP0532466A3 (en) Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
EP0506893A4 (en) Diagnosis and treatment of diseases
NO171398C (no) Patron for innfoering av et medisinsk middel
HU00207A9 (en) Sulfonanilide derivatives and medicine
NO922531D0 (no) Middel for forhindring av og behandling av fiskesykdommer
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
NO953003D0 (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
GB9216360D0 (en) Treatment of blood
NO171346C (no) Patron for innfoering av et medisinsk middel
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
ZA936136B (en) Treatment of skin diseases
ZA896503B (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
EG20171A (en) Treatment of conditions and disease
DK86093D0 (da) Praeparat til medikamentel behandling for tandlaegebrug mod lidelserne tandkoedsbetaendelse og tandnervebetaendelse
SK887U (sk) Zmes liečivých rastlín na liečenie nádorových a iných ochorení
NO900671L (no) Innretning for diagnostering og behandling av nesesykdommer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application